Larimar Therapeutics, Inc.(LRMR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LRMR Larimar Therapeutics, Inc.

交易中 05-02 13:58:06 EDT

2.98

+0.12

+4.20%

最高3.03	最低2.81	成交量113.80万
今开2.86	昨收2.86	日振幅7.69%
总市值1.91亿	流通市值8,176万	总股本6,403万
成交额332.59万	换手率4.15%	流通股本2,743万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LRMR","market":"US","secType":"STK","nameCN":"Larimar Therapeutics, Inc.","latestPrice":2.98,"timestamp":1746208678670,"preClose":2.86,"halted":0,"volume":1137990,"delay":0,"floatShares":27434946,"shares":64027892,"eps":-1.496554,"marketStatus":"交易中","change":0.12,"latestTime":"05-02 13:58:06 EDT","open":2.86,"high":3.03,"low":2.81,"amount":3325944.652716,"amplitude":0.076923,"askPrice":2.98,"askSize":500,"bidPrice":2.97,"bidSize":721,"shortable":3,"etf":0,"ttmEps":-1.496554,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746216000000},"marketStatusCode":2,"adr":0,"listingDate":1403150400000,"exchange":"NASDAQ","adjPreClose":2.86,"preHourTrading":{"tag":"盘前","latestPrice":2.9,"preClose":2.86,"latestTime":"09:25 EDT","volume":7419,"amount":21613.6028049,"timestamp":1746192335159},"postHourTrading":{"tag":"盘后","latestPrice":2.85,"preClose":2.86,"latestTime":"19:59 EDT","volume":10532,"amount":30473.2067,"timestamp":1746143950789},"volumeRatio":0.948495,"impliedVol":1.3494,"impliedVolPercentile":0.636},"requestUrl":"/m/hq/s/LRMR/wiki","defaultTab":"wiki","newsList":[{"id":"2532004945","title":"Larimar Therapeutics, Inc.盘中异动 急速上涨5.09%报2.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532004945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532004945?lang=zh_cn&edition=full","pubTime":"2025-05-01 23:11","pubTimestamp":1746112313,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日23时11分，Larimar Therapeutics, Inc.股票出现波动，股价急速上涨5.09%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家临床阶段的生物技术公司，专注于利用其创新的细胞穿透肽技术平台，为患有复杂罕见疾病的患者开发治疗方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501231154aa2c80d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501231154aa2c80d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LRMR","LENZ","BK4007"],"gpt_icon":0},{"id":"2528474577","title":"Larimar Therapeutics, Inc.盘中异动 大幅上涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528474577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528474577?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:55","pubTimestamp":1744898131,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时55分，Larimar Therapeutics, Inc.股票出现异动，股价大幅上涨5.43%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家临床阶段的生物技术公司，专注于利用其创新的细胞穿透肽技术平台，为患有复杂罕见疾病的患者开发治疗方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417215531aa2c7307&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417215531aa2c7307&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LRMR","LENZ","BK4007"],"gpt_icon":0},{"id":"2513733657","title":"Larimar Therapeutics, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513733657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513733657?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:38","pubTimestamp":1740411516,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时38分，Larimar Therapeutics, Inc.股票出现波动，股价大幅下挫5.02%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233836962ea893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233836962ea893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LRMR"],"gpt_icon":0},{"id":"2512667111","title":"Larimar Therapeutics, Inc.盘中异动 早盘股价大涨5.39%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512667111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512667111?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:50","pubTimestamp":1739890228,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时50分，Larimar Therapeutics, Inc.股票出现异动，股价急速拉升5.39%。截至发稿，该股报3.52美元/股，成交量5.0239万股，换手率0.08%，振幅4.94%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225028abd3b3a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225028abd3b3a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LRMR","LENZ"],"gpt_icon":0},{"id":"2508450756","title":"Larimar Therapeutics, Inc.盘中异动 早盘股价大涨5.01%报3.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508450756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508450756?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:03","pubTimestamp":1738681407,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时03分，Larimar Therapeutics, Inc.股票出现异动，股价急速上涨5.01%。截至发稿，该股报3.73美元/股，成交量3.8992万股，换手率0.06%，振幅4.23%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042303279617dd04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042303279617dd04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LRMR","LENZ"],"gpt_icon":0},{"id":"2507463516","title":"Larimar Therapeutics(LRMR.US)获Truist Securities首次覆盖，给予买入评级, 目标价18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507463516","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507463516?lang=zh_cn&edition=full","pubTime":"2025-01-29 21:35","pubTimestamp":1738157713,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics(LRMR.US)获Truist Securities首次覆盖，给予买入评级, 目标价18.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29213547898192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","LRMR"],"gpt_icon":0},{"id":"2503864263","title":"Larimar Therapeutics, Inc.盘中异动 股价大涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503864263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503864263?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951537,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Larimar Therapeutics, Inc.股票出现异动，股价急速上涨5.47%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.06%、52.88%、35.43%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为14.29%、12.00%、10.72%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232189604b414&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232189604b414&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LRMR"],"gpt_icon":0},{"id":"2503830295","title":"Larimar Therapeutics, Inc.盘中异动 早盘急速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503830295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503830295?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:36","pubTimestamp":1736779004,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时36分，Larimar Therapeutics, Inc.股票出现波动，股价急速下挫5.08%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.99%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3523.95%、2133.17%、393.34%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Phio Pharmaceuticals Corp.，振幅分别为104.79%、102.87%、61.54%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223644a22040e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223644a22040e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LRMR"],"gpt_icon":0},{"id":"2500240111","title":"Larimar Therapeutics, Inc.盘中异动 早盘大幅上涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500240111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500240111?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:36","pubTimestamp":1735914997,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时36分，Larimar Therapeutics, Inc.股票出现异动，股价大幅拉升5.24%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223637a2146a2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223637a2146a2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LRMR"],"gpt_icon":0},{"id":"2491134694","title":"Larimar Therapeutics, Inc.盘中异动 大幅跳水36.14%报3.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491134694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491134694?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:31","pubTimestamp":1734359476,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时31分，Larimar Therapeutics, Inc.股票出现异动，股价大幅下跌36.14%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223116a1f34279&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223116a1f34279&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LRMR"],"gpt_icon":0},{"id":"2490801276","title":"Larimar Therapeutics, Inc.盘中异动 早盘大幅下跌5.33%报6.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490801276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490801276?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:31","pubTimestamp":1733844668,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时31分，Larimar Therapeutics, Inc.股票出现波动，股价急速下跌5.33%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、Chimerix, Inc.较为活跃，换手率分别为1918.05%、439.66%、125.47%，振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Uniqure N.V.，振幅分别为154.91%、131.78%、42.77%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023310895e8b152&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023310895e8b152&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LRMR","LENZ","BK4139"],"gpt_icon":0},{"id":"2486503832","title":"Larimar Therapeutics, Inc.盘中异动 早盘大幅拉升5.03%报6.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486503832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486503832?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:40","pubTimestamp":1732545653,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时40分，Larimar Therapeutics, Inc.股票出现波动，股价急速拉升5.03%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.49%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224053a25491e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224053a25491e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LRMR","LENZ","BK4139"],"gpt_icon":0},{"id":"2480691581","title":"Larimar Therapeutics, Inc.盘中异动 大幅下挫5.43%报7.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480691581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480691581?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:37","pubTimestamp":1730731034,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时37分，Larimar Therapeutics, Inc.股票出现异动，股价快速跳水5.43%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223714a2154b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223714a2154b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LRMR","LENZ"],"gpt_icon":0},{"id":"2480885806","title":"Larimar Therapeutics, Inc.盘中异动 下午盘股价大跌5.17%报7.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480885806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480885806?lang=zh_cn&edition=full","pubTime":"2024-11-02 01:58","pubTimestamp":1730483938,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日01时58分，Larimar Therapeutics, Inc.股票出现波动，股价急速下挫5.17%。截至发稿，该股报7.80美元/股，成交量16.0319万股，换手率0.25%，振幅6.57%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110201585898e40113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110201585898e40113&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LRMR","BK4139"],"gpt_icon":0},{"id":"2479783790","title":"Larimar Therapeutics, Inc.盘中异动 早盘股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479783790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479783790?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:32","pubTimestamp":1730295123,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时32分，Larimar Therapeutics, Inc.股票出现波动，股价快速拉升5.40%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1767.79%、99.22%、15.91%，振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Cormedix Inc.，振幅分别为27.09%、11.49%、11.41%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021320395bd8e07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021320395bd8e07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LRMR","BK4139"],"gpt_icon":0},{"id":"2478722486","title":"Larimar Therapeutics, Inc.盘中异动 股价大涨5.62%报8.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478722486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478722486?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:46","pubTimestamp":1730123165,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时46分，Larimar Therapeutics, Inc.股票出现异动，股价快速上涨5.62%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214606a1f2552f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214606a1f2552f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LRMR"],"gpt_icon":0},{"id":"2478650446","title":"Larimar Therapeutics, Inc.盘中异动 下午盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478650446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478650446?lang=zh_cn&edition=full","pubTime":"2024-10-25 01:54","pubTimestamp":1729792473,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日01时54分，Larimar Therapeutics, Inc.股票出现波动，股价急速上涨5.03%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025015433971a21fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025015433971a21fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LRMR","BK4139"],"gpt_icon":0},{"id":"2472178619","title":"Larimar Therapeutics, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472178619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472178619?lang=zh_cn&edition=full","pubTime":"2024-10-03 21:45","pubTimestamp":1727963125,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日21时45分，Larimar Therapeutics, Inc.股票出现异动，股价急速拉升5.01%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003214525ab6798d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003214525ab6798d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LRMR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.larimartx.com","stockEarnings":[{"period":"1week","weight":0.2068},{"period":"1month","weight":0.43},{"period":"3month","weight":-0.2552},{"period":"6month","weight":-0.6305},{"period":"1year","weight":-0.6109},{"period":"ytd","weight":-0.261}],"compareEarnings":[{"period":"1week","weight":0.0215},{"period":"1month","weight":-0.0045},{"period":"3month","weight":-0.072},{"period":"6month","weight":-0.022},{"period":"1year","weight":0.1162},{"period":"ytd","weight":-0.0471}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Larimar Therapeutics, Inc.，于2005年11月22日根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，专注于利用公司新型细胞穿透肽（“CPP”）技术平台为患有复杂罕见疾病的患者开发治疗方法。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.102481},{"month":2,"riseRate":0.545455,"avgChangeRate":0.052852},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.145103},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.028256},{"month":5,"riseRate":0.545455,"avgChangeRate":-0.071012},{"month":6,"riseRate":0.5,"avgChangeRate":-0.021475},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.041896},{"month":8,"riseRate":0.454545,"avgChangeRate":0.084567},{"month":9,"riseRate":0.454545,"avgChangeRate":0.010818},{"month":10,"riseRate":0.636364,"avgChangeRate":-0.050678},{"month":11,"riseRate":0.636364,"avgChangeRate":0.050102},{"month":12,"riseRate":0.545455,"avgChangeRate":0.048319}],"exchange":"NASDAQ","name":"Larimar Therapeutics, Inc.","nameEN":"Larimar Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Larimar Therapeutics, Inc.(LRMR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Larimar Therapeutics, Inc.(LRMR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Larimar Therapeutics, Inc.,LRMR,Larimar Therapeutics, Inc.股票,Larimar Therapeutics, Inc.股票老虎,Larimar Therapeutics, Inc.股票老虎国际,Larimar Therapeutics, Inc.行情,Larimar Therapeutics, Inc.股票行情,Larimar Therapeutics, Inc.股价,Larimar Therapeutics, Inc.股市,Larimar Therapeutics, Inc.股票价格,Larimar Therapeutics, Inc.股票交易,Larimar Therapeutics, Inc.股票购买,Larimar Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Larimar Therapeutics, Inc.(LRMR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Larimar Therapeutics, Inc.(LRMR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}